PTSM: Pharmaceutical Technology Sourcing and Management, Jun 5, 2013 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Jun 5, 2013
Global Feature
A Pharma Industry Mid-Year Review and Outlook
By Patricia Van Arnum
Emerging markets remain strong as established markets fare less well.
APIs
Innovation in Sourcing and Procurement
By Patricia Van Arnum
The upcoming DCAT Sharp Sourcing 2013 conference addresses the challenges and opportunities in pharmaceutical sourcing and procurement.
Outsourcing
Outsourcing's Modest Role as a Cost-Containment Strategy
By Eric Langer
Outsourcing is weighing in more as a tactic for cost-cutting, but it is still not the primary weapon.
Pharma Partner Focus
Aesica in an Expansion Mode
By Patricia Van Arnum
The CMO Aesica has used a combination of organic growth and acquisitions to build its business and is seeking to expand its geographic footprint.
CSR and Sustainability Forum
Pharma News in Global Health and Sustainability
A roundup of developments in global health and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.
Pharma Industry Participates in Global Health Initiatives
By Patricia Van Arnum
Highlights from the 66th World Health Assembly and the pharmaceutical industry?s role in addressing noncommunicable diseases, mental and neurological disorders, R&D for diseases of the developing world, counterfeit medicines, the global vaccine action plan, and neglected tropical diseases.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here